Parvovirus B19-associated systemic lupus erythematosus: Clinical mimicry or autoimmune induction?

Journal of Rheumatology

Volumn 37, Issue 11, 2010, Pages 2430-2432

  Hession, Meghan T ^a   Shiu Chung, A U ^a   Gottlieb, Alice B ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DAPSONE; HYDROXYCHLOROQUINE; HYDROXYZINE; METHOTREXATE; PREDNISONE;

ANTIBODY TITER; AUTOIMMUNE DISEASE; FATIGUE; FLUSHING; HUMAN PARVOVIRUS B19; LETTER; PARVOVIRUS INFECTION; PATHOGENESIS; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; URTICARIA;

FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 78149236706     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100345     Document Type: Letter

References (16)

1. Lunardi C, Tinazzi E, Bason C, Dolcino M. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev 2008;8:116-20.
2. Seve P, Ferry T, Koenig M, Cathebras P, Rousset H, Broussolle C. Lupus-like presentation of parvovirus B19 infection. Semin Arthritis Rheum 2004;34:642-8.
3. Garcia F, Domingo-Domenech E, Castro-Bohoquez FJ, Biosca M, Garcia-Quintana A, Perez-Vega C, et al. Lupus like presentation of parvovirus B19. Am J Med 2001;111:573-7.
4. Nesher G, Osborn TG, Moore TL. Parvovirus B19 infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum 1995;24:297-303.
5. Sugimoto T, Tsuda A, Uzu T, Kashiwagi A. Emerging lupus-like manifestations in acute parvovirus B19 infection. Clin Rheumatol 2008;27:119-20.
6. Kalt M, Gertner E. Antibodies to B2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus. J Rheumatol 2001;28:2335-6.
7. Tanaka A, Sugawara A, Sawai K, Kuwahara T. Human parvovirus B19 infection resembling systemic lupus erythematosus. Intern Med 1998;37:708-10.
8. Tovari E, Mezey I, Hedman K, Czirjak L. Self limiting lupus-like symptoms in patients with parvovirus B19 infection. Ann Rheum Dis 2002;61:662-3.
9. Vigeant P, Menard HA, Boire G. Chronic modulation of the auto-immune response following parvovirus B19. J Rheumatol 1994;21:1165-7.
10. Nigro G, Piazze J, Taliani G, Mazzocco M, Cassinotti P, Cosmi EV. Postpartum lupus erythematosus associated with parvovirus B19 infection. J Rheumatol 1997;24:968-70.
11. Fawaz-Estrup F. Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. J Rheumatol 1996;23:1180-5.
12. Crowson AN, Magro CM, Dawood MR. A causal role for parvovirus B29 infection in adult dermatomyositis and other autoimmune disorders. J Cutan Pathol 2000;27:505-15.
13. Cope AP, Jones A, Brozovic M, Shafi MS, Maini RN. The possible induction of systemic lupus erythematosus by human parvovirus. Ann Rheum Dis 1992;51:803-4.
14. Gran JT, Johnse V, Myklebust G, Nordba S. The variable clinical picture of arthritis induced by human parvovirus B19. Scand J Rheumatol 1995;24:174-9.
15. Diaz F, Collazos J, Mendoza F, De la Viuda JM, Cazallas J, Urkijo JC, et al. Systemic lupus erythematosus associated with acute parvovirus B19 infection. Clin Microbiol Infect 2002;8:115-7.
16. Ideguchi H, Ohno S, Ishigatsubo Y. A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection. Rheumatol Int 2007;27:411-4.